PF-06869206
PF-06869206 is an orally bioavailable selective inhibitor of the sodium-phosphate cotransporter NaPi2a (SLC34A1) with an IC50 of 380 nM[1].
Product Specifications
CAS Number
2227425-05-8
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Sodium Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
Neuroscience-Neuromodulation
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/PF-06869206.html
Purity
99.88
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
ClC1=C(C)NC2=C(N3C[C@@H](CO)OCC3)C(C#N)=C(C(F)(F)F)N=C21
Molecular Formula
C15H14ClF3N4O2
Molecular Weight
374.75
Precautions
H302, H315, H319, H335
References & Citations
[1]Filipski KJ, et al. Discovery of Orally Bioavailable Selective Inhibitors of the Sodium-Phosphate Cotransporter NaPi2a (SLC34A1) . ACS Med Chem Lett. 2018 Apr 12;9 (5) :440-445.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-H817340-250MG 250 mg
2-hydroxy-6-(4-hydroxyphenethyl)benzoic acid
Sign In for Pricing
View Details 
